Atherosclerotic cardiovascular disease in inflammatory bowel disease:The role of chronic inflammation
作者机构：Department of MedicineHackensack Meridian Health Palisades Medical CenterNorth BergenNJ 07047United States Division of Gastroenterology and HepatologyMedical College of WisconsinMilwaukeeWI 53226United States Department of MedicineUniversity of South Dakota Sanford School of MedicineSioux FallsSD 57108United States Department of MedicineNew York PresbyterianBrooklynNY 11215United States Department of MedicineMount Sinai-Saint Luke’s RooseveltNY 10025United States Division of Gastroenterology and HepatologyUniversity of California Davis School of MedicineSacramentoCA 95817United States Division of GastroenterologyDepartment of MedicineOlive View-UCLA Medical CenterSylmarCA 91342United States David Geffen School of Medicine at UCLALos AngelesCA 90001United States
出 版 物：《World Journal of Gastrointestinal Pathophysiology》 (世界胃肠病理生理学杂志（英文版）（电子版）)
年 卷 期：2020年第11卷第5期
页 面：104-113页
学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学]
主 题：Crohn’s disease Ulcerative colitis Atherosclerosis Thromboembolism Chronic inflammation Pathophysiology
摘 要：Inflammatory bowel disease(IBD)causes systemic vascular *** increased risk of venous as well as arterial thromboembolic phenomena in IBD is well *** recently,a relationship between IBD and atherosclerotic cardiovascular disease(ASCVD)has been *** inflammatory diseases,such as rheumatoid arthritis and systemic lupus erythematosus,have well characterized cardiac pathologies and treatments that focus on prevention of disease associated *** impact of chronic inflammation on ASCVD in IBD remains poorly *** manuscript aims to review and summarize the current literature pertaining to IBD and ASCVD with respect to its pathophysiology and impact of medications in order to encourage further research that can improve understanding and help develop clinical recommendations for prevention and management of ASCVD in patients with IBD.
维普期刊数据库